Table 2.

General recommendations for melanoma care at a glance

The COVID‐19 pandemic mandates precautions to minimize the risk of infections, while ensuring most effective cancer care

Teledermatology is a valuable tool in times of lockdown and limitation of face‐to‐face visits

The initiation of adjuvant and therapeutic melanoma therapy should not be delayed during the COVID‐19 pandemic

Treatment decisions require the consideration of individual risk factors and melanoma characteristics

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.